[
  {
    "ts": null,
    "headline": "BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 6, 2025 to discuss the Company's financial results for its fourth quarter and full year of fiscal 2025, which ended on September 30, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be",
    "url": "https://finnhub.io/api/news?id=a657de9a338b87fd38f3eca1ce1377975752dd227a9e0b3c3f89f24fad72dd3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760040900,
      "headline": "BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025",
      "id": 137042027,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 6, 2025 to discuss the Company's financial results for its fourth quarter and full year of fiscal 2025, which ended on September 30, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be",
      "url": "https://finnhub.io/api/news?id=a657de9a338b87fd38f3eca1ce1377975752dd227a9e0b3c3f89f24fad72dd3d"
    }
  },
  {
    "ts": null,
    "headline": "Becton Dickinson & Co. stock underperforms Thursday when compared to competitors",
    "summary": "Becton Dickinson & Co. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=ca2f52293ce98b19a63aca1dce42cb82ba1da8936787ade282ab2a677263062a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760028480,
      "headline": "Becton Dickinson & Co. stock underperforms Thursday when compared to competitors",
      "id": 137084232,
      "image": "",
      "related": "BDX",
      "source": "MarketWatch",
      "summary": "Becton Dickinson & Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=ca2f52293ce98b19a63aca1dce42cb82ba1da8936787ade282ab2a677263062a"
    }
  },
  {
    "ts": null,
    "headline": "BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery disease (PAD) lesions.",
    "url": "https://finnhub.io/api/news?id=dcef42f652d81d6d9f4d8e64dab546d4f0091430ab91f6136a5e177bf589f1bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760007000,
      "headline": "BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease",
      "id": 137031342,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery disease (PAD) lesions.",
      "url": "https://finnhub.io/api/news?id=dcef42f652d81d6d9f4d8e64dab546d4f0091430ab91f6136a5e177bf589f1bc"
    }
  }
]